星昊医药：2025年年度业绩快报公告

Group 1 - The company, Xinghao Pharmaceutical, announced that it expects to achieve an operating revenue of 652,092,358.80 yuan in 2025, representing a year-on-year growth of 0.62% [2] - The net profit attributable to shareholders of the listed company is projected to be 105,963,063.09 yuan, reflecting a year-on-year increase of 27.85% [2]